CLINICAL_TRIALS
trial_result
· 2016-09-01
Clinical Trial Update: Study of Trilipix Effects on Lipids and Arteries [Phase 4]
Summary
A Phase 4 trial assessing Trilipix effects on lipids and arterial health in dyslipidemia was terminated, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Utah | Conditions: Dyslipidemia | Phase 4 | Status: TERMINATED | Results posted: 2016-09-01